A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Genentech, Inc.
Kahr Medical
Hoffmann-La Roche
Genentech, Inc.
Replimune, Inc.
ImmunityBio, Inc.
Exelixis
Exelixis
Genentech, Inc.
Seattle Project Corporation
Kahr Medical
Gritstone bio, Inc.
Exelixis
Keythera (Suzhou) Pharmaceuticals Co. Ltd
Hoffmann-La Roche
Amgen
Hoffmann-La Roche
Hoffmann-La Roche
Fate Therapeutics
Fate Therapeutics
Hoffmann-La Roche
Hoffmann-La Roche